Republic Healthcare Limited (HK:8357)
:8357
Top Page
Republic Healthcare Limited
(8357)
Select Model
Select Model
Rating:43Neutral
Price Target:
HK$0.12
▲(0.83% Upside)
Action:ReiteratedDate:03/29/26
The score is driven primarily by weak financial performance (worsening 2025 losses, declining revenue, and negative operating/free cash flow) and added balance-sheet risk from the 2025 debt increase. Technical indicators also lean bearish with the price below key moving averages and negative MACD. Valuation is not supportive because the negative P/E reflects ongoing losses and no dividend yield data is available.
Positive Factors
Conservative balance sheet history
A multi-year track record of low leverage (2021–2024) indicates the company historically preserved financial flexibility. That conservatism can help absorb cyclical shocks, support funding access, and provide runway for operational adjustments when performance weakens.
Negative Factors
Worsening profitability
A gross loss and materially larger operating/net losses signal deteriorating unit economics and margin erosion. Persistent multi-year revenue declines (~10% then ~8%) reduce scale benefits, squeeze margins, and undermine reinvestment capacity, making earnings recovery harder without structural change.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet history
A multi-year track record of low leverage (2021–2024) indicates the company historically preserved financial flexibility. That conservatism can help absorb cyclical shocks, support funding access, and provide runway for operational adjustments when performance weakens.
Read all positive factors
Republic Healthcare Limited (8357) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$87.98M
Dividend YieldN/A
Average Volume (3M)282.67K
Price to Earnings (P/E)―
Beta (1Y)0.16
Revenue Growth-11.68%
EPS Growth-71.01%
CountryHK
Employees34
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)-0.02
Shares Outstanding624,000,000
10 Day Avg. Volume457,500
30 Day Avg. Volume282,666
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)1.51
Price to Sales (P/S)1.84
P/FCF Ratio-4.63
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Republic Healthcare Limited Business Overview & Revenue Model
Company Description
Republic Healthcare Limited, a primary healthcare services company, provides consultation, medical investigation, and treatment services in Singapore. The company offers various treatment solutions for common medical conditions and focuses on sexu...
Republic Healthcare Limited Financial Statement Overview
Summary
Income Statement
22
Negative
Balance Sheet
54
Neutral
Cash Flow
28
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.51M | 7.84M | 9.23M | 10.28M | 9.44M | 13.97M |
| Gross Profit | 1.67M | -23.92K | 6.48M | 2.70M | 5.97M | 9.13M |
| EBITDA | -1.30M | -1.76M | -188.79K | 29.34K | -387.88K | 962.89K |
| Net Income | -1.25M | -2.96M | -178.16K | -855.12K | -1.48M | -997.93K |
Balance Sheet | ||||||
| Total Assets | 13.65M | 16.14M | 14.48M | 15.64M | 16.42M | 19.27M |
| Cash, Cash Equivalents and Short-Term Investments | 9.75M | 6.85M | 11.52M | 11.93M | 11.83M | 14.27M |
| Total Debt | 1.25M | 5.03M | 858.22K | 961.16K | 810.47K | 1.55M |
| Total Liabilities | 2.34M | 6.59M | 1.93M | 2.89M | 2.30M | 3.67M |
| Stockholders Equity | 11.31M | 9.55M | 12.55M | 12.75M | 14.12M | 15.59M |
Cash Flow | ||||||
| Free Cash Flow | -1.22M | -3.12M | 51.27K | 806.24K | -1.16M | -1.13M |
| Operating Cash Flow | -1.15M | -1.90M | 125.07K | 899.91K | -734.46K | -510.07K |
| Investing Cash Flow | 1.24M | -2.22M | -93.94K | 831.49K | -987.23K | -1.56M |
| Financing Cash Flow | -560.42K | -813.99K | -531.65K | -587.62K | -689.73K | 2.28M |
Republic Healthcare Limited Technical Analysis
Neutral
0.12
Price Trends
0.16
Negative
0.15
Negative
0.15
Negative
Market Momentum
-0.01
Positive
42.95
Neutral
26.36
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8357, the sentiment is Neutral. The current price of 0.12 is below the 20-day moving average (MA) of 0.15, below the 50-day MA of 0.16, and below the 200-day MA of 0.15, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 42.95 is Neutral, neither overbought nor oversold. The STOCH value of 26.36 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:8357.
Republic Healthcare Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | HK$160.98M | 5.31 | 6.92% | 8.00% | -21.50% | -43.25% | |
58 Neutral | HK$56.34M | 362.73 | -19.93% | ― | -2.91% | 55.41% | |
53 Neutral | HK$22.46M | -197.60 | 138.68% | ― | -20.81% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
43 Neutral | HK$87.98M | -4.87 | -27.01% | ― | -11.68% | -71.01% | |
42 Neutral | HK$134.15M | -20.58 | -1449.22% | ― | -30.45% | -734.38% | |
41 Neutral | HK$16.65M | -2.29 | 26.12% | ― | 14.64% | -81.95% |
* Healthcare Sector Average
HK:8357
Republic Healthcare Limited
0.14
0.07
98.59%
HK:8143
Good Fellow Healthcare Holdings Limited
0.12
0.06
116.36%
HK:2293
Bamboos Health Care Holdings Ltd
0.40
-0.13
-24.53%
HK:8161
MediNet Group Ltd.
0.54
0.20
58.82%
HK:8307
Medicskin Holdings Ltd.
0.14
>-0.01
-5.33%
HK:8437
RMH Holdings Limited
0.25
0.08
47.06%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.